Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Trainor

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Biochemical Pharmacology|June 17, 2000
Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinedionesJ Marcinkeviciene, M J Rogers, L Kopcho, et al.
Journal of Medicinal Chemistry|June 19, 1998
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analoguesG V De Lucca, U T Kim, J Liang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Synthesis, antiviral activity and pharmacokinetics of P1/P1' substituted 3-aminoindazole cyclic urea HIV protease inhibitorsRobert F Kaltenbach, Mona Patel, Robert E Waltermire, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2009
Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)Tram Huynh, Zhong Chen, Suhong Pang, et al.
Journal of Medicinal Chemistry|October 4, 2002
Parallel synthesis of potent, pyrazole-based inhibitors of Helicobacter pylori dihydroorotate dehydrogenaseTasir S Haque, Seifu Tadesse, Jovita Marcinkeviciene, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkASoong-Hoon Kim, John S Tokarski, Kenneth J Leavitt, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Quinazolines as cyclin dependent kinase inhibitorsT M Sielecki, T L Johnson, J Liu, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3Eddy W Yue, Susan V DiMeo, C Anne Higley, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivityPaul S Watson, Bin Jiang, Kim Harrison, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|June 17, 2000
Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinedionesJ Marcinkeviciene, M J Rogers, L Kopcho, et al.
Journal of Medicinal Chemistry|June 19, 1998
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analoguesG V De Lucca, U T Kim, J Liang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Synthesis, antiviral activity and pharmacokinetics of P1/P1' substituted 3-aminoindazole cyclic urea HIV protease inhibitorsRobert F Kaltenbach, Mona Patel, Robert E Waltermire, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2009
Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)Tram Huynh, Zhong Chen, Suhong Pang, et al.
Journal of Medicinal Chemistry|October 4, 2002
Parallel synthesis of potent, pyrazole-based inhibitors of Helicobacter pylori dihydroorotate dehydrogenaseTasir S Haque, Seifu Tadesse, Jovita Marcinkeviciene, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkASoong-Hoon Kim, John S Tokarski, Kenneth J Leavitt, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Quinazolines as cyclin dependent kinase inhibitorsT M Sielecki, T L Johnson, J Liu, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3Eddy W Yue, Susan V DiMeo, C Anne Higley, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivityPaul S Watson, Bin Jiang, Kim Harrison, et al.
Pageof 11